These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23727142)

  • 41. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coated capsules for drug targeting to proximal and distal part of human intestine.
    Dvorácková K; Rabisková M; Gajdziok J; Vetchý D; Muselík J; Bernatoniene J; Bajerová M; Drottnerová P
    Acta Pol Pharm; 2010; 67(2):191-9. PubMed ID: 20369797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.
    Li J; Yang L; Ferguson SM; Hudson TJ; Watanabe S; Katsuma M; Fix JA
    AAPS PharmSciTech; 2002; 3(4):E33. PubMed ID: 12916927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral colon delivery of insulin with the aid of functional adjuvants.
    Maroni A; Zema L; Del Curto MD; Foppoli A; Gazzaniga A
    Adv Drug Deliv Rev; 2012 May; 64(6):540-56. PubMed ID: 22086142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-controlled oral delivery systems for colon targeting.
    Gazzaniga A; Maroni A; Sangalli ME; Zema L
    Expert Opin Drug Deliv; 2006 Sep; 3(5):583-97. PubMed ID: 16948555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Film Coating Designs for Colon-Targeted Oral Delivery.
    Tran PHL; Tran TTD
    Curr Med Chem; 2021; 28(10):1957-1969. PubMed ID: 32496984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel dissolution method for evaluation of polysaccharide based colon specific delivery systems: A suitable alternative to animal sacrifice.
    Singh SK; Yadav AK; Prudhviraj G; Gulati M; Kaur P; Vaidya Y
    Eur J Pharm Sci; 2015 Jun; 73():72-80. PubMed ID: 25829049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. pH-dependent ileocolonic drug delivery, part II: preclinical evaluation of novel drugs and novel excipients.
    Broesder A; Kosta AMAC; Woerdenbag HJ; Nguyen DN; Frijlink HW; Hinrichs WLJ
    Drug Discov Today; 2020 Aug; 25(8):1374-1388. PubMed ID: 32562842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Azo compounds in colon-specific drug delivery.
    Roldo M; Barbu E; Brown JF; Laight DW; Smart JD; Tsibouklis J
    Expert Opin Drug Deliv; 2007 Sep; 4(5):547-60. PubMed ID: 17880276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polysaccharides for colon targeted drug delivery.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(2):129-48. PubMed ID: 15200012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colon drug delivery.
    Van den Mooter G
    Expert Opin Drug Deliv; 2006 Jan; 3(1):111-25. PubMed ID: 16370944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preclinical models for colonic absorption, application to controlled release formulation development.
    Lozoya-Agullo I; González-Álvarez I; Merino-Sanjuán M; Bermejo M; González-Álvarez M
    Eur J Pharm Biopharm; 2018 Sep; 130():247-259. PubMed ID: 30064699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel salicylazo polymers for colon drug delivery: dissolving polymers by means of bacterial degradation.
    Saphier S; Karton Y
    J Pharm Sci; 2010 Feb; 99(2):804-15. PubMed ID: 19603504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic opportunities in colon-specific drug-delivery systems.
    Patel M; Shah T; Amin A
    Crit Rev Ther Drug Carrier Syst; 2007; 24(2):147-202. PubMed ID: 17725524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified-release solid formulations for colonic delivery.
    Singh BN
    Recent Pat Drug Deliv Formul; 2007; 1(1):53-63. PubMed ID: 19075874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A combination of pH-sensitive caplet coatings may be an effective noninvasive strategy to deliver bioactive substances, nutrients, or their precursors to the colon.
    Aimone AM; Connolly B; Chaudhary S; Lugtu-Pe J; Martinuzzi F; Pencharz P; O'Connor DL
    Appl Physiol Nutr Metab; 2009 Oct; 34(5):893-900. PubMed ID: 19935851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.
    Jain A; Gupta Y; Jain SK
    J Pharm Pharm Sci; 2007; 10(1):86-128. PubMed ID: 17498397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro.
    Siew LF; Man SM; Newton JM; Basit AW
    Int J Pharm; 2004 Apr; 273(1-2):129-34. PubMed ID: 15010137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review.
    Vats A; Pathak K
    Expert Opin Drug Deliv; 2013 Apr; 10(4):545-57. PubMed ID: 23316745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.